GI & Endoscopy

Exact Sciences posted third-quarter 2019 revenues of $218.8 million, an 85 percent year-over-year increase.

Exact Sciences posted revenues of $218.8 million in the third quarter of 2019 and screened some 456,000 people with Cologuard.

Sang H. Kim, MD, is the chief of gastroenterology at NewYork-Presbyterian Queens in New York City.

Here are five of the most read articles on gastroenterology this week:

Strong consolidation activity characterized the physician services sector in the third quarter of 2019, according to Provident Healthcare Partners' "Q3-2019 Physician Services Update."

Current RDD Pharma CEO John Temperato elaborated on the thinking behind the Innovate and RDD Pharma merger to Becker's ASC Review and offered insights into what's expected after the merger closes and 9 Meters Biopharma is formed. 

Here are five updates from gastroenterology companies and practices from the past week: 

Gastroenterologists are spending more on indemnity rates and malpractice defense, according to a study presented at ACG 2019 in San Antonio, Oct. 25-30, reported on by MD.

The National Cancer Institute awarded two universities a $5.7 million grant to increase colorectal cancer screening rates in the Appalachia region of the U.S.

Steven Fine, MD, is the chief of the gastroenterology department and endoscopy services at the MetroWest Medical Center in Framingham, Mass.